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Introduction
Q‑fever, an ubiquitous zoonotic disease, is the result of a 
resistant, obligate intracellular gram‑negative bacterium 
Coxiella burnetii that infects humans after coming 
in contact with an infected animal or contaminated 
environment or aerosols.[1‑3] Inhalation of airborne 
C. burnetii bacterium from contaminated animal birth 
fluids/placental tissues or dust contaminated with 
animal excreta or fluids is the most frequent means 
of transmission to humans.[2] Transmission can also 
occur through direct contact with infected animals, 
primarily cattle, sheep, and goats, and their products, 
such as wool, raw milk, or manure/fertilizer.[2,3] There 
have been reports of Q‑fever cases related to human 
exposure to pigeons, dogs, and rabbits and of the 
possibility of transmission of infection via ticks due 
to the fact that about 40 species of ticks have been 
found to carry C. burnetii.[2,4] According to the Centers 
for Disease Control and Prevention (CDC), 3% of 
healthy adults in the United States have antibodies to 
C. burnetii along with 10‑20% of adults in high‑risk 
occupations such as veterinarians and farmers, this 
suggests past infection with the bacteria.[1] C. burnetii 
is highly infectious only requiring a single organism 
to cause disease, in addition it is resistant to heat and 
drying, and has the ability to survive months to years 
in an environment. 
Persons infected with Q‑fever can develop either 
an acute or chronic form of the illness. In general, 
symptoms of acute illness develop 2‑3 weeks after an 
exposure.[1] There are estimates that between 50% and 
60% of cases are asymptomatic.[2,4] The most common 
symptoms reported with acute Q‑fever are fever, 
malaise, chills and/or sweats, headache, and myalgia. 
The patients may frequently present clinically with a 
nonspecific febrile illness that could include pneumonia 
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or hepatitis.[2,4] The mortality rate for acute Q‑fever 
is 1‑2%.[4] Of acutely infected individuals, <5% will 
develop chronic Q‑fever symptoms. The range of onset 
from acute infection to chronic illness can be anywhere 
from 6 weeks to months, years or decades after the 
initial infection.[2,5] Chronic Q‑fever can develop after 
symptomatic or asymptomatic infections. The patients 
may present with endocarditis (60‑78% of cases), 
infection of aneurysms or vascular prostheses (second 
most common form), chronic infection after pregnancy 
(third most common form), chronic hepatitis, 
osteomyelitis, septic arthritis, chronic pulmonary 
infections, and chronic fatigue syndrome.[2,4,5] The 
mortality rate for chronic Q‑fever endocarditis is 
reported by CDC as 25‑60% in untreated patients.[1]
Clinical Case
A 62‑year‑old Nepalese male with past medical history 
notable for type‑2 diabetes mellitus, gastroesophageal 
reflux disease, hypertension, hyperlipidemia, remote 
history of alcohol abuse, tobacco smoking history, 
and latent tuberculosis (TB) infection presented with 
intermittent fevers and lethargy of about 3 weeks. The 
patient came to the United States as a refugee from 
Nepal in 2010 and had not traveled abroad since then. 
He was treated with 9 months of isoniazid (INH) for 
a positive TB skin test with negative chest x‑ray as a 
part of the refugee TB program at the Monroe County 
Department of Public Health (MCDPH), Rochester, NY. 
The patient first presented to his primary care 
physician (PCP) on 24 January 2014 with complaints 
of fatigue and fever and was told he was likely to have 
influenza. He then went to the emergency department 
at Strong Memorial Hospital (SMH) in Monroe County, 
NY on 26 January 2014 for fevers and an episode of 
nonbilious emesis. He was treated with intravenous 
(IV) fluids and discharged home after stabilization. 
Labs at that time were fairly unremarkable showing 
only mild elevation in liver function tests (LFTs), 
aspartate aminotransferase (AST) = 103, and the 
alanine aminotransferase (ALT) = 81.
He was admitted at SMH on 7 February 2014 for 
persistent fevers, nausea, emesis, and abnormal LFTs 
including hyperbilirubinemia with clinical jaundice. 
There was a significant language barrier initially for 
the providers, but the infectious disease (ID) doctor 
was able to glean history from the patient when it 
was realized that both could communicate in Hindi. 
History was also obtained from his family members 
who spoke English. According to his sons, the patient 
had fever up to 102 degrees Fahrenheit at home. He 
denied diarrhea, rash, dysuria, headache, back pain, 
abdominal pain, arthralgia, or myalgia. There was a 
history of osteoarthritis of both knees with occasional 
swelling for the past 2 years that was unchanged. The 
patient also denied cough, congestion, sore throat, or 
flu‑like symptoms. The patient denied recent sexual 
activity. No drug allergies were noted. He did not 
have pets at home. His current home medications 
included Neurontin, Lantus, Tylenol, and Prilosec. 
He was mildly confused at presentation, for which a 
computed tomography (CT) head scan was negative for 
acute findings. He had a temperature of 101.5 degrees 
Fahrenheit on the day of admission. CT of the abdomen/
pelvis showed splenomegaly, thickened gallbladder, 
fatty liver, and mildly enlarged periportal lymph nodes. 
His influenza and respiratory syncytial virus (RSV) 
tests were negative and blood cultures had remained 
sterile. Stool studies were unrevealing. Inflammatory 
markers, such as erythrocyte sedimentation rate (ESR) 
and C‑reactive protein (CRP), were elevated at 85 and 
135, respectively. He was treated for about 48 h with 
broad spectrum anti‑infective agents including Zosyn 
(Piperacillin/Tazobactam), which was discontinued 
with unrevealing culture data. Daily fevers that ranged 
between 100.4 degrees Fahrenheit and 102.2 degrees 
Fahrenheit persisted, which are suggestive of a 
noninfectious etiology or an infection secondary to 
a pathogen not covered by the antibiotic. His LFTs 
started to trend to normal but remained elevated at 
the time of the ID consult. The patient was found to 
be immune to hepatitis B and testing for Hepatitis C 
was negative. Cytomegalovirus (CMV) was negative, 
and Epstein–Barr virus (EBV) was immunoglobulin G 
(IgG) positive and immunoglobulin M (IgM) negative. 
Blood Cultures x 6 showed no growth. Clostridium 
difficile was negative, and serum ferritin was 1845. 
His total iron binding capacity (TIBC) was low at 203 
(250‑450 µg/dL) as was his iron saturation of 30 (45‑
170 ug/dL). Antimitochondrial antibody (AMA) and 
F‑Actin antibody (Ab) were elevated at 34 (0‑20 units) 
and 45 (0‑19 units), respectively, smooth muscle Ab, 
IgG titer was <1:20.
On examination, his vital signs were stable, he was 
alert, but appeared chronically ill and fatigued. His 
neck was supple, no cervical lymphadenopathy and no 
oral lesions were observed, and his dental hygiene was 
poor. A lung exam revealed bibasilar crackles. His heart 
had a regular rate and rhythm without murmur or rub. 
The abdomen was soft and nontender without masses. 
No spinal or costovertebral angle tenderness was 
elicited. His extremities had trace edema, no peripheral 
stigmata endocarditis and no rash was noted. 
The ID team requested further infectious work‑up, 
including serum cryptococcal antigen (Ag), Syphilis 
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screen; Brucella Ab, hepatitis E and A, and human 
immunodeficiency virus (HIV) 1 and 2 Ag/Ab were 
negative. He had normal renal function and his 
blood chemistry was unremarkable except for mild 
hyponatremia of 124 that went as low as 121 on day 6 
of admission. The complete blood count did not have 
leukocytosis or any remarkable findings except mild 
thrombocytopenia. Haptoglobin was mildly elevated 
at 250 mg/dL, and on flow cytometry his cluster of 
differentiation 4 (CD4) count was 320. Angiotensin‑
converting enzyme (ACE) levels were normal and 
Ceruloplasmin levels were only mildly elevated at 38 
(0‑30 mg/dL).
With respect to imaging, the abdominal CT was 
unrevealing for any hepatic or splenic lesions but 
showed some periportal lymph node enlargement; chest 
CT revealed small effusion with no consolidations, 
hepatobiliary (HIDA) scan and transthoracic 
echocardiogram (TTE) were both negative for any 
abnormalities. A liver biopsy was performed on 24 
February 2014, which showed macrovesicular steatosis; 
mild steatohepatitis; well‑formed nonnecrotizing 
granulomas; and portal, periportal, and pericellular 
fibrosis. Up to this point, the patient continued with 
almost daily low‑grade fevers of unknown origin 
(FUO) so testing for uncommon pathogens was then 
considered, including Q‑fever serology testing; as 
well as getting a bone marrow biopsy to evaluate for 
granulomatous disease and possible miliary TB. A 
malaria (Vivax/Ovale) smear was requested and was 
negative. After 20 days of admission, fevers abated 
and patient remained afebrile for more than 48 h. In 
light of increasing patient and family frustration, the 
patient was discharged home with only the C. burnetti 
serology pending. The patient was instructed to return 
to the emergency department if fever resumed or new 
symptoms developed. 
Up to this time, no epidemiological link was recognized 
and the patient’s presentation led ID doctors to believe 
that some sort of autoimmune phenomenon could 
be causing the symptoms. When the Q‑fever results 
came back positive, the patient was called by ID and 
asked to come in for evaluation and treatment. At 
this clinic visit on 21 March 2014, the patient’s son 
confirmed that their family (along with a large part 
of the Nepalese community) had been going to an 
upstate NY animal farm to buy fresh goat meat. This 
established a convincing epidemiological link. The 
son also reported that the animals were slaughtered by 
the farm owner and then the family skinned the goat 
themselves. No animal parturition was witnessed, but 
young calves were in the vicinity. Other than feeling 
tired and fatigued, the patient was now asymptomatic 
and afebrile at home, with the return of his appetite 
as well. Although the ID doctors did not feel the 
patient had risk factors associated with progression 
to a chronic Q‑fever infection (valvular heart disease, 
endovascular grafts, arterial aneurysms, and/or an 
immunocompromised state) as a precaution, the 
patient was given treatment with doxycycline 100 mg 
orally twice daily for 2 weeks. The patient followed up 
in 4 weeks at the infectious disease clinic at SMH. At 
the 4‑week follow‑up appointment, the patient had 
completed his 2 weeks of treatment with doxycycline, 
he was jovial and more energetic and denied fevers or 
any other symptoms. 
Epidemiological investigation
On 11 March 2014, the MCDPH received serum 
positive results for Q‑fever IgG antibody (Ab) for phase I 
(4,096) and phase II (65,536) and positive IgM Ab for 
phase I (16,384) and phase II (262,144) (collected on 
25 February 2014 at SMH) from a reference lab via the 
New York State (NYS) Electronic Clinical Laboratory 
Reporting System (ECLRS). In addition, an ECLRS 
report was received on 3/19/14 showing a positive 
C. Burnetti DNA, qualitative real‑time PCR collected 
on 25 February 2014 on this patient. All New York 
State (NYS) local health departments are mandated 
to investigate positive lab results on suspected cases 
of Q‑fever under NYS sanitary code 10 NYCRR 2.10, 
2/14.[6] The investigation began with contacting the 
PCP and a review of the hospital record. The PCP did 
not have any information on possible exposures to 
Q‑fever, but was concerned after review of the recent 
hospital admission. A Nepalese interpreter was used 
by the PCP, who was familiar with this patient and 
was able to give the MCDPH a phone number for the 
patient’s son, who spoke English. Convalescent blood 
testing for Q‑fever IgG and IgM was drawn on 16 March 
2014 for confirmation. The MCDPH interviewed the 
patient’s son on 19 March 2014. The NYS Q‑fever 
questionnaire was used in this proxy interview, which 
included questions regarding the case’s symptoms and 
onset date, travel history, and contact with livestock/
animals or their products. The son reported that his 
father was disabled and did not work. The patient lived 
with his wife and two sons. No contacts of the patient 
were reported as ill with similar symptoms. The onset 
of symptoms was reported as around 20 January 14 
with fever, weakness, and then confusion that brought 
him to the hospital. The patient reportedly had no 
travel since coming to the United States several years 
ago. Exposure to animals was initially denied, until 
further questioning with regard to types of food eaten 
and where they shopped/acquired their food revealed 
that the family goes to a farm to get chickens and goat 
meat about once every month. This farm is located in a 
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different county about 1.5 h away from Monroe County. 
They do not consume raw milk or other dairy products 
from this farm. It was described as a large farm with 
goats, sheep, pigs, rabbits, chickens, which are being 
sold for meat, with a slaughterhouse onsite where the 
consumer can kill their own animal or have the farm 
staff kill it. The patient and his family (four sons) all 
went to this farm where they went into the fields and 
physically caught and carried a goat on 29 December 
2013, 22 days prior to the patient’s onset of symptoms. 
The patient was involved in this process and handled 
the goat. The goat was then brought to the onsite 
slaughterhouse where the farm staff killed the goat and 
packaged it up for the family to take home to consume. 
On the same visit, the family also purchased a chicken 
that they killed themselves in the farm slaughterhouse 
and then brought home to consume. 
Results
It was learned later in the investigation that an additional 
serum specimen was taken from the patient at SMH 
on 8 February 2014 (at the beginning of his hospital 
admission), these sample results were not initially 
reported by the reference lab, but also came back IgG 
and IgM positive as well as DNA PCR positive. Per the 
request of the NYS Department of Health (NYSDOH), 
the Q‑fever IgG serum specimen drawn from the patient 
on 25 February 2014 was forwarded by the reference 
lab to the NYSDOH Wadsworth Laboratory, Albany, 
NY, and was confirmed positive for phase I (8,192) and 
phase II (32,768) antibodies. Of note when the number 
of phase II antibodies is higher than that of the phase 
I antibodies, the results suggest acute infection with 
Q‑fever.[2] Convalescent testing done on 16 March 
2014 came back from the reference lab showing IgG 
AB’s for phase I (4,096) and phase II (262,144), these 
results show greater than a fourfold rise in phase II 
IgG results between acute and convalescent titers thus 
confirming Acute Q‑fever in this patient.[2] 
Public health response
After the MCDPH discovered the likely source of this 
Q‑fever case, the next steps were to ensure follow‑up/
treatment of the patient, surveillance of other possible 
cases, and follow‑up with the farm. At the initial 
interview with the patient the MCDPH recommended 
that the patient follow‑up with SMH regarding 
treatment and follow‑up testing, this was the PCP’s 
recommendation as well. The name of the farm, where 
the patient was exposed to livestock was unknown at 
the initial proxy interview, but this information was 
captured by the ID team at SMH at the follow‑up 
visit and passed it on to the MCDPH. The NYSDOH 
was contacted early on in this investigation by the 
MCDPH for guidance and recommendations regarding 
testing, interpretation of results, and surveillance. The 
NYSDOH was able to confirm that no other recent 
Q‑fever cases in New York had exposure to the same 
farm as this case. The NYSDOH also reached out to the 
county where the farm was located to inform them of 
this case’s exposure and ask about possible cases in the 
area, which there were none. The MCDPH requested 
that the NYSDOH reach out to the NYS Department of 
Agriculture and Markets (NYS Ag and Mkts) with regard 
to contacting the farm owner to discuss the connection 
between his farm and this case and provide education. 
A doctor from the NYS Ag and Mkts was able to speak 
with the farm owner on this matter. Discussion points 
included how common Q‑fever is in sheep, goats, and 
cattle, cautioning the farmer on the handling of birth 
fluids/ fetal membranes/placentae of livestock, which 
includes taking steps to minimize exposure to persons 
on his farm (in fields and slaughterhouses), and not 
letting the public assist with animal births. In addition, 
the farmer was educated on regulations regarding the 
sale of unpasteurized milk and milk products. It was 
recommended that owners/employees/consumers 
with concerns about their health after exposure to the 
farm should be directed to a physician or local health 
department. The ID doctors at SMH also offered to 
this patient and his family to see any member of the 
Nepalese community who was experiencing symptoms 
and had a similar exposure at the goat farm.
Conclusion
The incidence of Q‑fever in NYS per the NYSDOH 
from 2009‑2014 has been 24 confirmed cases. Per the 
NYSDOH, there have been six confirmed cases in the 
Western New York Region, where Monroe County is 
located during that time frame. It has been speculated 
that C. burnetii could be an unknown cause of cases of 
community‑acquired pneumonia, this is most likely due 
to the fact that it cannot be distinguished “from other 
causes of community‑acquired pneumonia solely on 
the basis of radiographic findings.”[2] Physicians should 
suspect acute Q‑fever in patients with pneumonia, a 
prolonged fever of greater than 10 days, and an increase 
in liver enzymes.[2]
There have been outbreaks of Q‑fever in the 
Netherlands from 2007 to 2009, which reported 
around 4,000 cases, with about 50% of acute cases 
being hospitalized, as well as an outbreak in the United 
States (Washington and Montana) in 2011 with 21 
identified cases.[5,7,8] This illustrates the possibility of 
large outbreaks of Q‑fever.[2,5,7,8] Bjork et al. (2011 US 
outbreak) point out that many patients, including an 
11‑year‑old child, suffered long durations of illness 
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(months) and even had an appendectomy, because they 
were not properly diagnosed and did not receive proper 
treatment.[8] Exposure history from the Monroe County 
case was not known during hospitalization and test 
results for Q‑fever were not available, so a diagnosis of 
Q‑fever was not made and treatment was not started. 
If a clinician is suspecting Q‑fever treatment should 
not be delayed and should ideally be started within 
3 days of onset to decrease the length and risk for 
complication of Q‑fever.[2,8] Doxycycline is the most 
effective treatment.[2] 
It is important for health‑care professionals to obtain 
a complete history of their patients to include the 
following information: Occupation, where they live, 
contact with someone who has been ill, travel history, 
any farm or domestic animal exposures (or exposure 
to animal products), blood transfusion history, tick 
exposure, along with the clinical picture, to evaluate for 
a possible Q‑fever diagnosis and to make appropriate 
treatment decisions.[2] 
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